Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis

Table 2 Summarized clinical history of ulcerative colitis patients who used biologics in both study and control group

No.	Age at diagnosis	Sex	Initial endoscopic finding	No. of systemic steroid use	Indication for biologics	History of biologics	Colectomy
1	21	F	RS	4	Steroid dependent	infliximab	-
2	30	F	RS	2	Steroid refractory	Infliximab (failed)	+
3	31	F	RS	9	Steroid dependent	golimumab	-
4	35	M	RS	2	Steroid refractory	Infliximab (failed)	+
5	15	F	RI	3	Steroid refractory	golimumab
6	22	F	RI	1	Steroid refractory	Infliximab (failed)	+
7	20	F	RI	7	Steroid dependent	golimumab topacitinib	-
8	33	M	RI	4	Steroid refractory	infliximab	-
9	34	M	RI	2	Steroid refractory	Infliximab (failed)	+
10	35	M	RI	4	Steroid refractory	golimumab	-
11	39	M	RI	3	Steroid refractory	golimumab	-
12	41	F	RI	4	Steroid dependent	golimumab	-
13	44	M	RI	5	Steroid refractory	golimumab	-
14	48	M	RI	2	Steroid refractory	golimumab	-

RS: Rectal sparing; RI: Rectal involvement.